Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-02-20 @ 6:39 PM
Study NCT ID:
NCT00615433
Status:
COMPLETED
Last Update Posted:
2015-06-12
First Post:
2008-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-01
Start Date Type:
None
Primary Completion Date:
2009-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-01
First Submit QC Date:
None
Study First Post Date:
2008-02-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-11-08
Results First Submit QC Date:
None
Results First Post Date:
2011-02-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-19
Last Update Post Date:
2015-06-12
Last Update Post Date Type:
ESTIMATED